0 XP   0   0   0

ZENOTECH LABORATORIES LTD.
Buy, Hold or Sell?

Should you buy, hold or sell ZENOTECH LABORATORIES LTD.?

I guess you are interested in ZENOTECH LABORATORIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse ZENOTECH LABORATORIES LTD.

Let's start. I'm going to help you getting a better view of ZENOTECH LABORATORIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is ZENOTECH LABORATORIES LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how ZENOTECH LABORATORIES LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value ZENOTECH LABORATORIES LTD.. The closing price on 2023-01-31 was INR57.05 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
ZENOTECH LABORATORIES LTD. Daily Candlestick Chart
ZENOTECH LABORATORIES LTD. Daily Candlestick Chart
Summary









1. Valuation of ZENOTECH LABORATORIES LTD.




Current price per share

INR57.05

2. Growth of ZENOTECH LABORATORIES LTD.




Is ZENOTECH LABORATORIES LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$8.6m$5.9m$2.7m31.5%

How much money is ZENOTECH LABORATORIES LTD. making?

Current yearPrevious yearGrowGrow %
Making money$2.7m-$149.4k$2.8m105.5%
Net Profit Margin60.6%-6.3%--

How much money comes from the company's main activities?

3. Financial Health of ZENOTECH LABORATORIES LTD.




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of ZENOTECH LABORATORIES LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ZENOTECH LABORATORIES LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare ZENOTECH LABORATORIES LTD. to the  industry mean.
  • A Net Profit Margin of 60.6% means that ₹0.61 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ZENOTECH LABORATORIES LTD.:

  • The MRQ is 60.6%. The company is making a huge profit. +2
  • The TTM is 60.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ60.6%TTM60.6%0.0%
TTM60.6%YOY-6.3%+66.9%
TTM60.6%5Y-6.9%+67.5%
5Y-6.9%10Y-152.6%+145.8%
1.1.2. Return on Assets

Shows how efficient ZENOTECH LABORATORIES LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ZENOTECH LABORATORIES LTD. to the  industry mean.
  • 23.6% Return on Assets means that ZENOTECH LABORATORIES LTD. generated ₹0.24 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ZENOTECH LABORATORIES LTD.:

  • The MRQ is 23.6%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 23.6%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ23.6%TTM23.6%0.0%
TTM23.6%YOY-1.4%+25.0%
TTM23.6%5Y3.3%+20.3%
5Y3.3%10Y-3.8%+7.1%
1.1.3. Return on Equity

Shows how efficient ZENOTECH LABORATORIES LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ZENOTECH LABORATORIES LTD. to the  industry mean.
  • 31.4% Return on Equity means ZENOTECH LABORATORIES LTD. generated ₹0.31 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ZENOTECH LABORATORIES LTD.:

  • The MRQ is 31.4%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 31.4%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ31.4%TTM31.4%0.0%
TTM31.4%YOY-2.5%+33.9%
TTM31.4%5Y2.9%+28.5%
5Y2.9%10Y2.4%+0.5%

1.2. Operating Efficiency of ZENOTECH LABORATORIES LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ZENOTECH LABORATORIES LTD. is operating .

  • Measures how much profit ZENOTECH LABORATORIES LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ZENOTECH LABORATORIES LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ZENOTECH LABORATORIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-29.3%+29.3%
5Y-29.3%10Y-129.8%+100.5%
1.2.2. Operating Ratio

Measures how efficient ZENOTECH LABORATORIES LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.78 means that the operating costs are ₹0.78 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of ZENOTECH LABORATORIES LTD.:

  • The MRQ is 0.783. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.783. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.783TTM0.7830.000
TTM0.783YOY1.285-0.502
TTM0.7835Y0.995-0.212
5Y0.99510Y0.952+0.042

1.3. Liquidity of ZENOTECH LABORATORIES LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if ZENOTECH LABORATORIES LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 0.47 means the company has ₹0.47 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of ZENOTECH LABORATORIES LTD.:

  • The MRQ is 0.473. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.473. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.473TTM0.4730.000
TTM0.473YOY0.491-0.018
TTM0.4735Y0.469+0.004
5Y0.46910Y0.394+0.076
1.3.2. Quick Ratio

Measures if ZENOTECH LABORATORIES LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ZENOTECH LABORATORIES LTD. to the  industry mean.
  • A Quick Ratio of 0.42 means the company can pay off ₹0.42 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ZENOTECH LABORATORIES LTD.:

  • The MRQ is 0.417. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.417. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.417TTM0.4170.000
TTM0.417YOY0.428-0.011
TTM0.4175Y0.404+0.014
5Y0.40410Y0.337+0.066

1.4. Solvency of ZENOTECH LABORATORIES LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ZENOTECH LABORATORIES LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ZENOTECH LABORATORIES LTD. to industry mean.
  • A Debt to Asset Ratio of 0.25 means that ZENOTECH LABORATORIES LTD. assets are financed with 24.9% credit (debt) and the remaining percentage (100% - 24.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ZENOTECH LABORATORIES LTD.:

  • The MRQ is 0.249. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.249. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.249TTM0.2490.000
TTM0.249YOY0.436-0.187
TTM0.2495Y0.426-0.177
5Y0.42610Y0.738-0.312
1.4.2. Debt to Equity Ratio

Measures if ZENOTECH LABORATORIES LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ZENOTECH LABORATORIES LTD. to the  industry mean.
  • A Debt to Equity ratio of 33.2% means that company has ₹0.33 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ZENOTECH LABORATORIES LTD.:

  • The MRQ is 0.332. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.332. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.332TTM0.3320.000
TTM0.332YOY0.773-0.441
TTM0.3325Y0.790-0.458
5Y0.79010Y0.658+0.132

2. Market Valuation of ZENOTECH LABORATORIES LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings ZENOTECH LABORATORIES LTD. generates.

  • Above 15 is considered overpriced but always compare ZENOTECH LABORATORIES LTD. to the  industry mean.
  • A PE ratio of 16.80 means the investor is paying ₹16.80 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ZENOTECH LABORATORIES LTD.:

  • The EOD is 15.701. Very good. +2
  • The MRQ is 16.802. Very good. +2
  • The TTM is 16.802. Very good. +2
Trends
Current periodCompared to+/- 
EOD15.701MRQ16.802-1.101
MRQ16.802TTM16.8020.000
TTM16.802YOY-192.117+208.919
TTM16.8025Y-51.641+68.443
5Y-51.64110Y-44.127-7.514
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of ZENOTECH LABORATORIES LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of ZENOTECH LABORATORIES LTD.:

  • The MRQ is 0.830. Good. +1
  • The TTM is 0.830. Good. +1
Trends
Current periodCompared to+/- 
MRQ0.830TTM0.8300.000
TTM0.830YOY1,704.013-1,703.183
TTM0.8305Y330.114-329.284
5Y330.11410Y330.1140.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ZENOTECH LABORATORIES LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 5.27 means the investor is paying ₹5.27 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of ZENOTECH LABORATORIES LTD.:

  • The EOD is 4.929. Neutral. Compare to industry.
  • The MRQ is 5.275. Seems overpriced? -1
  • The TTM is 5.275. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD4.929MRQ5.275-0.346
MRQ5.275TTM5.2750.000
TTM5.275YOY4.822+0.452
TTM5.2755Y5.186+0.089
5Y5.18610Y3.992+1.194
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ZENOTECH LABORATORIES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.6433.6430%-0.200+105%5.949-39%1.929+89%
Book Value Growth--1.4591.4590%0.975+50%1.455+0%1.455+0%
Book Value Per Share--11.57511.5750%7.932+46%8.179+42%3.788+206%
Book Value Per Share Growth--1.4591.4590%0.975+50%1.403+4%1.403+4%
Current Ratio--0.4730.4730%0.491-4%0.469+1%0.394+20%
Debt To Asset Ratio--0.2490.2490%0.436-43%0.426-42%0.738-66%
Debt To Equity Ratio--0.3320.3320%0.773-57%0.790-58%0.658-50%
Dividend Per Share----0%-0%-0%-0%
Eps--3.6343.6340%-0.199+105%0.549+562%-0.455+113%
Eps Growth--20.25020.2500%-0.113+101%5.793+250%5.793+250%
Free Cash Flow Per Share--2.5772.5770%0.136+1796%-1.506+158%-1.212+147%
Free Cash Flow Per Share Growth--18.96318.9630%2.080+812%2.056+822%2.056+822%
Free Cash Flow To Equity Per Share---0.023-0.0230%0.210-111%-0.073+215%-0.051+122%
Free Cash Flow To Equity Per Share Growth---0.110-0.1100%2.098-105%15.887-101%15.887-101%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--64.428--------
Intrinsic Value_10Y_min--53.956--------
Intrinsic Value_1Y_max--3.421--------
Intrinsic Value_1Y_min--3.324--------
Intrinsic Value_3Y_max--12.592--------
Intrinsic Value_3Y_min--11.851--------
Intrinsic Value_5Y_max--24.552--------
Intrinsic Value_5Y_min--22.354--------
Net Profit Margin--0.6060.6060%-0.063+110%-0.069+111%-1.526+352%
Operating Margin----0%-0%-0.2930%-1.2980%
Operating Ratio--0.7830.7830%1.285-39%0.995-21%0.952-18%
Pb Ratio4.929-7%5.2755.2750%4.822+9%5.186+2%3.992+32%
Pe Ratio15.701-7%16.80216.8020%-192.117+1243%-51.641+407%-44.127+363%
Peg Ratio--0.8300.8300%1704.013-100%330.114-100%330.114-100%
Price Per Share57.050-7%61.05061.0500%38.250+60%41.850+46%40.862+49%
Price To Total Gains Ratio15.661-7%16.75916.7590%-191.220+1241%-46.378+377%-38.978+333%
Profit Growth--20.25020.2500%-0.113+101%5.745+252%5.745+252%
Quick Ratio--0.4170.4170%0.428-3%0.404+3%0.337+24%
Return On Assets--0.2360.2360%-0.014+106%0.033+612%-0.038+116%
Return On Equity--0.3140.3140%-0.025+108%0.029+993%0.024+1212%
Revenue Growth--1.8871.8870%0.747+153%2.148-12%2.148-12%
Total Gains Per Share--3.6433.6430%-0.200+105%5.949-39%1.929+89%
Total Gains Per Share Growth--20.21120.2110%-0.114+101%5.779+250%5.779+250%
Usd Book Value--8688732.3008688732.3000%5954208.600+46%6139992.720+42%3765577.350+131%
Usd Book Value Change Per Share--0.0450.0450%-0.002+105%0.073-39%0.024+89%
Usd Book Value Per Share--0.1420.1420%0.098+46%0.101+42%0.047+206%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0450.0450%-0.002+105%0.007+562%-0.006+113%
Usd Free Cash Flow--1934777.7001934777.7000%102028.500+1796%-636775.920+133%-530646.600+127%
Usd Free Cash Flow Per Share--0.0320.0320%0.002+1796%-0.019+158%-0.015+147%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.003-111%-0.001+215%-0.001+122%
Usd Price Per Share0.702-7%0.7510.7510%0.470+60%0.515+46%0.503+49%
Usd Profit--2727635.7002727635.7000%-149457.300+105%412303.380+562%-63722.200+102%
Usd Revenue--4497507.3004497507.3000%2382915.900+89%2608830.000+72%2220236.100+103%
Usd Total Gains Per Share--0.0450.0450%-0.002+105%0.073-39%0.024+89%
 EOD+3 -2MRQTTM+0 -0YOY+30 -85Y+29 -910Y+33 -5

3.2. Fundamental Score

Let's check the fundamental score of ZENOTECH LABORATORIES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1515.701
Price to Book Ratio (EOD)Between0-14.929
Net Profit Margin (MRQ)Greater than00.606
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.417
Current Ratio (MRQ)Greater than10.473
Debt to Asset Ratio (MRQ)Less than10.249
Debt to Equity Ratio (MRQ)Less than10.332
Return on Equity (MRQ)Greater than0.150.314
Return on Assets (MRQ)Greater than0.050.236
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of ZENOTECH LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose57.200
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets940,836
Total Liabilities234,435
Total Stockholder Equity706,401
 As reported
Total Liabilities 234,435
Total Stockholder Equity+ 706,401
Total Assets = 940,836

Assets

Total Assets940,836
Total Current Assets73,747
Long-term Assets73,747
Total Current Assets
Cash And Cash Equivalents 24,148
Short-term Investments 1,575
Net Receivables 39,282
Other Current Assets 8,134
Total Current Assets  (as reported)73,747
Total Current Assets  (calculated)73,139
+/- 608
Long-term Assets
Property Plant Equipment 711,881
Other Assets 124,193
Long-term Assets  (as reported)867,089
Long-term Assets  (calculated)836,074
+/- 31,015

Liabilities & Shareholders' Equity

Total Current Liabilities155,755
Long-term Liabilities78,680
Total Stockholder Equity706,401
Total Current Liabilities
Accounts payable 20,662
Other Current Liabilities 11,817
Total Current Liabilities  (as reported)155,755
Total Current Liabilities  (calculated)32,479
+/- 123,276
Long-term Liabilities
Long term Debt Total 60,000
Long-term Liabilities Other 9,829
Long-term Liabilities  (as reported)78,680
Long-term Liabilities  (calculated)69,829
+/- 8,851
Total Stockholder Equity
Common Stock610,306
Retained Earnings -1,999,336
Capital Surplus 2,095,431
Total Stockholder Equity (as reported)706,401
Total Stockholder Equity (calculated)706,401
+/-0
Other
Capital Stock610,306
Cash and Short Term Investments 24,148
Common Stock Shares Outstanding 61,031
Liabilities and Stockholders Equity 940,836
Net Debt 35,852
Net Invested Capital 766,401
Net Working Capital -82,008



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
507,473
817,413
845,833
855,540
858,441
940,836
940,836858,441855,540845,833817,413507,473
   > Total Current Assets 
18,184
314,204
191,943
57,067
73,459
73,747
73,74773,45957,067191,943314,20418,184
       Cash And Cash Equivalents 
0
0
130,000
5,000
24,577
24,148
24,14824,5775,000130,00000
       Short-term Investments 
0
0
0
0
1,414
1,575
1,5751,4140000
       Net Receivables 
1,109
5,041
27,981
20,356
38,032
39,282
39,28238,03220,35627,9815,0411,109
       Inventory 
9,797
9,014
6,265
1,052
862
1,347
1,3478621,0526,2659,0149,797
       Other Current Assets 
2,051
15,652
25,148
24,142
8,817
8,134
8,1348,81724,14225,14815,6522,051
   > Long-term Assets 
0
0
653,890
798,473
784,982
867,089
867,089784,982798,473653,89000
       Property Plant Equipment 
468,334
467,548
600,600
778,114
764,139
711,881
711,881764,139778,114600,600467,548468,334
       Long-term Assets Other 
0
0
0
0
2
1
120000
> Total Liabilities 
1,166,538
397,237
456,850
359,250
374,359
234,435
234,435374,359359,250456,850397,2371,166,538
   > Total Current Liabilities 
1,164,150
394,467
453,478
354,360
149,472
155,755
155,755149,472354,360453,478394,4671,164,150
       Short-term Debt 
512,000
0
202,400
186,562
0
0
00186,562202,4000512,000
       Short Long Term Debt 
0
0
202,400
186,562
0
0
00186,562202,40000
       Accounts payable 
51,342
54,132
41,153
46,023
19,219
20,662
20,66219,21946,02341,15354,13251,342
       Other Current Liabilities 
1,672
1,929
33,427
3,813
11,046
11,817
11,81711,0463,81333,4271,9291,672
   > Long-term Liabilities 
0
0
3,372
4,890
224,887
78,680
78,680224,8874,8903,37200
       Long term Debt Total 
0
0
0
0
206,562
60,000
60,000206,5620000
       Long-term Liabilities Other 
0
0
0
0
9,986
9,829
9,8299,9860000
> Total Stockholder Equity
-659,065
420,176
388,983
496,290
484,082
706,401
706,401484,082496,290388,983420,176-659,065
   Common Stock
344,275
610,306
610,306
610,306
610,306
610,306
610,306610,306610,306610,306610,306344,275
   Retained Earnings Total Equity000000
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 
0
0
2,095,431
2,095,431
2,095,431
2,095,431
2,095,4312,095,4312,095,4312,095,43100
   Treasury Stock000000
   Other Stockholders Equity 000-221,32300



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue365,651
Cost of Revenue-25,538
Gross Profit340,113340,113
 
Operating Income (+$)
Gross Profit340,113
Operating Expense-260,752
Operating Income104,89979,361
 
Operating Expense (+$)
Research Development-
Selling General Administrative164,046
Selling And Marketing Expenses-
Operating Expense260,752164,046
 
Net Interest Income (+$)
Interest Income11,193
Interest Expense-12,152
Net Interest Income-11,166-959
 
Pretax Income (+$)
Operating Income104,899
Net Interest Income-11,166
Other Non-Operating Income Expenses-
Income Before Tax (EBT)99,013104,899
EBIT - interestExpense = -12,152
221,759
233,911
Interest Expense12,152
Earnings Before Interest and Taxes (ebit)-111,165
Earnings Before Interest and Taxes (ebitda)180,900
 
After tax Income (+$)
Income Before Tax99,013
Tax Provision--122,746
Net Income From Continuing Ops221,759221,759
Net Income221,759
Net Income Applicable To Common Shares221,759
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-11,166
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
SVY.AU
16 minutes ago

I found you a Golden Cross on the daily chart of SVY.AU.

SVY.AU Daily Candlestick Chart
SPT.AU
20 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of SPT.AU.

SPT.AU Daily Candlestick Chart
SMP.AU
24 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SMP.AU.

SMP.AU Daily Candlestick Chart
SGP.AU
29 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGP.AU.

SGP.AU Daily Candlestick Chart
SDR.AU
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SDR.AU.

SDR.AU Daily Candlestick Chart
RMS.AU
36 minutes ago

I found you a Golden Cross on the daily chart of RMS.AU.

RMS.AU Daily Candlestick Chart
PLL.AU
57 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PLL.AU.

PLL.AU Daily Candlestick Chart
PGD.AU
58 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PGD.AU.

PGD.AU Daily Candlestick Chart
OML.AU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OML.AU.

OML.AU Daily Candlestick Chart
MVA.AU
1 hour ago

I found you a Golden Cross on the daily chart of MVA.AU.

MVA.AU Daily Candlestick Chart
BRX.AU
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of BRX.AU.

BRX.AU Daily Candlestick Chart
HTG.AU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HTG.AU.

HTG.AU Daily Candlestick Chart
SLB.AU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SLB.AU.

SLB.AU Daily Candlestick Chart
GLA.AU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GLA.AU.

GLA.AU Daily Candlestick Chart
ENX.AU
1 hour ago

I found you a Three Black Crows Candle Pattern on the daily chart of ENX.AU.

ENX.AU Daily Candlestick Chart
GLH.AU
1 hour ago

I found you a Rising Three Methods Candle Pattern on the daily chart of GLH.AU.

GLH.AU Daily Candlestick Chart
PLT.AU
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of PLT.AU.

PLT.AU Daily Candlestick Chart
GRX.AU
1 hour ago

I found you a MACD Bullish Hidden Divergence on the daily chart of GRX.AU.

GRX.AU Daily Candlestick Chart
HVY.AU
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of HVY.AU.

HVY.AU Daily Candlestick Chart
BMG.AU
1 hour ago

I found you a RSI Bullish Reversal Divergence on the daily chart of BMG.AU.

BMG.AU Daily Candlestick Chart
EVZ.AU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of EVZ.AU.

EVZ.AU Daily Candlestick Chart
ANX.AU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ANX.AU.

ANX.AU Daily Candlestick Chart
NGS.AU
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of NGS.AU.

NGS.AU Daily Candlestick Chart
MHK.AU
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MHK.AU.

MHK.AU Daily Candlestick Chart